Recombinetics Announces Major Advancements in the Development of a Novel Swine Model of Neurofibromatosis Type 1
Recombinetics announced the development of the first-of-their-kind gene-edited swine models for Neurofibromatosis Type 1 (NF1). Partially funded by the Children’s Tumor Foundation, and in collaboration with the University of Minnesota, these models are for use in preclinical safety and efficacy testing of therapeutics for this debilitating genetic disease affecting 1 [...]
Recombinetics Awarded Two NIH Grants to Develop Humanized Swine Models of Alzheimer’s Disease and Neurofibromatosis 2
Recombinetics announces the receipt of two Small Business Innovative Research (SBIR) grant awards from the National Institutes of Health totaling more than $700,000. The first grant from the National Institute on Aging is to develop a genetically accurate swine model of Alzheimer’s disease. The second grant from the National Institute [...]
